# US Oxygen Therapy Device Market

> US Oxygen Therapy Device Market Research Report: Size, Share, Trend Analysis By Types (Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders, Portable Oxygen Devices, Oxygen Accessories), By Applications (Chronic Obstructive Pulmonary Disease, Asthma, Respiratory Distress Syndrome, Sleep Apnea, Cystic Fibrosis), By End Use (Hospitals, Home Care Settings, Emergency Medical Services, Long-term Care Facilities) and By Technology (Continuous Flow Technology, Pulse Dose Technology, Hybrid Oxygen Therapy) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.82%
- **2024:** $ 594.08 Million
- **2025:** $ 634.6 Million
- **2035:** $ 1,227.54 Million
- **Key Players:** Philips (NL), ResMed (AU), Breas Medical (SE), Invacare (US), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), Nidek Medical (JP), Caire Inc. (US)

**Report ID:** MRFR/MED/16457-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Garvit Vyas · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/us-oxygen-therapy-device-market-17985

---

## Market Summary

## **US Oxygen Therapy Device Market Overview**

As per MRFR analysis, the US Oxygen Therapy Device Market Size was estimated at 771.75 (USD Million) in 2023. The US Oxygen Therapy Device Market Industry is expected to grow from 810 (USD Million) in 2024 to 1,250 (USD Million) by 2035. The US Oxygen Therapy Device Market CAGR (growth rate) is expected to be around 4.023% during the forecast period (2025 - 2035).

### **Key US Oxygen Therapy Device Market Trends Highlighted**

The US Oxygen Therapy Device Market is witnessing significant trends shaped by an aging population, increased prevalence of respiratory diseases, and a growing focus on home healthcare. The Centers for Disease Control and Prevention (CDC) indicates that chronic respiratory conditions like COPD and asthma are major health issues, driving the demand for oxygen therapy devices. Enhanced awareness of the benefits of oxygen therapy for conditions such as sleep apnea and pulmonary hypertension also boosts market growth. Key market drivers include advancements in technology that allow for portable and more efficient oxygen delivery systems, which enhance patient mobility and comfort.

The push for home-based care solutions has increased the demand for user-friendly, lightweight devices that can be easily used outside clinical settings. Additionally, regulatory support and policies aimed at improving access to oxygen therapy contribute to the market expansion. Opportunities to be explored include the rise of telehealth services, which can facilitate remote monitoring and management of patients utilizing oxygen therapy. This trend aligns with the growing interest in integrated healthcare solutions that streamline patient care and enhance outcomes.

Trends in recent times also show a shift towards personalized medicine, with devices being developed to meet the specific needs of individual patients. The increasing adoption of refillable and environmentally friendly options points towards a sustainable approach in the oxygen therapy sector, appealing to environmentally conscious consumers. Overall, these factors collectively shape a dynamic market landscape in the US oxygen therapy device sector, offering various avenues for growth and innovation.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **US Oxygen Therapy Device Market Drivers**

#### **Increasing Incidence of Chronic Respiratory Diseases**

The rising prevalence of chronic respiratory diseases in the United States is a significant driver for the US Oxygen Therapy Device Market Industry. According to the Centers for Disease Control and Prevention (CDC), around 16 million Americans are diagnosed with Chronic Obstructive Pulmonary Disease (COPD), a condition that significantly increases the need for supplemental oxygen. Moreover, as the aging population grows, with projections indicating that by 2030, the number of individuals aged 65 and older will reach about 73 million, this demographic shift will lead to a higher demand for oxygen therapy devices.

Organizations like the American Lung Association are advocating for better respiratory health, which further incentivizes technological advancements and investments in oxygen therapy solutions. These factors contribute to an increasing market base for oxygen therapy devices as more patients require long-term oxygen treatment, thereby bolstering market growth in the US.

#### **Technological Advancements in Oxygen Therapy Devices**

Rapid advancements in the technology used in oxygen therapy devices are driving the growth of the US Oxygen Therapy Device Market Industry. Innovations such as portable oxygen concentrators and digital health integration have significantly improved the convenience and effectiveness of oxygen therapy. The Food and Drug Administration (FDA) has approved numerous devices that enhance patient adherence through digital monitoring features. For example, portable devices now weigh less than 5 pounds, making them more accessible for patients.

Companies like Philips and ResMed are leading the charge in developing user-friendly, technologically advanced devices that not only meet clinical needs but also offer enhanced lifestyle compatibility. The ongoing Research and Development efforts in the sector indicate a robust pipeline of innovations, contributing to market growth as more patients adopt these modern solutions.

#### **Surge in Demand for Home Healthcare Services**

The increase in demand for home healthcare services in the United States is a crucial driver for the US Oxygen Therapy Device Market Industry. With more patients opting for home care solutions post-hospitalization, the adoption of oxygen therapy devices in home healthcare is rapidly expanding. The American Association for Homecare has reported that about 12 million Medicare beneficiaries received home healthcare services in the past year, highlighting the shift towards at-home treatment options.

As healthcare policies increasingly support home healthcare through reimbursements and care models that prioritize patient comfort, the demand for oxygen therapy devices that can be used safely and effectively in residential settings is on the rise. This trend not only advocates for improved patient outcomes but also enhances market opportunities for manufacturers focusing on home-use oxygen delivery systems.

#### **Government Initiatives and Healthcare Policies**

Government initiatives aimed at improving respiratory healthcare and reducing hospital readmissions are significantly impacting the US Oxygen Therapy Device Market Industry. The Centers for Medicare & Medicaid Services (CMS) have implemented policies that focus on managing chronic respiratory conditions, which includes the provision of oxygen therapy to eligible patients. These initiatives are designed to enhance access to necessary therapies, subsequently increasing the patient population that requires oxygen therapy devices. Furthermore, various state-level programs are reinforcing these national efforts by offering additional support and funding for patients needing oxygen therapy solutions.

With the federal government committing substantial resources to enhance healthcare accessibility, the oxygen therapy device market is expected to thrive as continuous improvements in healthcare policy solidify the importance of effective respiratory care.

### **US Oxygen Therapy Device Market Segment Insights**

#### **Oxygen Therapy Device Market Type Insights**

The US Oxygen Therapy Device Market, particularly focusing on the Type category, presents a diverse array of products aimed at addressing respiratory conditions requiring oxygen therapy. This extensive market is characterized by several crucial categories such as Oxygen Concentrators, Liquid Oxygen Systems, Oxygen Cylinders, Portable Oxygen Devices, and Oxygen Accessories. Each of these plays a vital role in enhancing the quality of life for patients suffering from various respiratory ailments. Oxygen Concentrators have gained significant traction due to their ability to provide continuous oxygen supply directly from the atmosphere, proving to be both convenient and economical.

Liquid Oxygen Systems are notable for their storage efficiency, allowing for greater oxygen supply at a lower volume, a key advantage for individuals needing long-term therapy. Oxygen Cylinders persist as an important component of oxygen therapy, particularly useful in emergency situations and in healthcare facilities where portability and immediate access to oxygen are critical. Portable Oxygen Devices have transformed the approach to oxygen therapy, granting patients increased freedom and mobility, which is essential for maintaining daily activities and social engagements.

The growth of this segment is largely driven by an increased demand for home-based therapies and an aging population that requires chronic disease management. Lastly, Oxygen Accessories, including various delivery systems and fittings, play a supportive role in ensuring optimal functionality and comfort for patients, underscoring the interdependency of these devices within the market. The combination of these types exhibits the ongoing trends toward more adaptable, user-friendly, and effective solutions in the oxygen therapy landscape within the US, reflecting the industry's responsiveness to patient needs and preferences.

Overall, the US Oxygen Therapy Device Market segmentation by Type illustrates a robust and dynamic sector focused on improving respiratory health outcomes.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

#### **Oxygen Therapy Device Market Application Insights**

The Application segment of the US Oxygen Therapy Device Market plays a crucial role in addressing various respiratory conditions. Chronic Obstructive Pulmonary Disease (COPD) is a leading cause of morbidity in the US, necessitating the widespread use of oxygen therapy for symptom management and improved quality of life. Asthma, affecting millions of individuals, often requires supplemental oxygen, especially during exacerbations. Respiratory Distress Syndrome, commonly seen in neonates and adults, highlights the urgent need for effective oxygen therapy solutions in critical care settings.

Sleep apnea, a prevalent disorder, relies on oxygen therapy devices to enhance nocturnal breathing patterns, significantly improving patient outcomes. Cystic Fibrosis also plays a significant role, with oxygen therapy assisting in managing the chronic lung infections that characterize the condition. Overall, the Application segment reflects vital utilization trends and challenges in respiratory healthcare, facilitated by advancements in technology and continued research in oxygen therapy.

#### **Oxygen Therapy Device Market End Use Insights**

The US Oxygen Therapy Device Market is extensively segmented by End Use, including critical areas such as Hospitals, Home Care Settings, Emergency Medical Services, and Long-term Care Facilities. Hospitals remain a key domain, often utilizing advanced oxygen therapy devices to support patients with severe respiratory disorders and chronic lung conditions. In Home Care Settings, the increasing prevalence of respiratory diseases among the aging population significantly boosts demand for portable oxygen solutions, allowing patients to maintain a better quality of life while managing their conditions in comfort.

Emergency Medical Services play a crucial role in the rapid provision of oxygen therapy during critical situations, showcasing the importance of quick response technology and reliability. Meanwhile, Long-term Care Facilities are essential for providing continuous oxygen therapy to patients with chronic respiratory issues, indicating a steady need for oxygen delivery systems tailored to long-term usage. As these segments evolve, trends reveal a growing focus on the development of more user-friendly, efficient, and cost-effective oxygen devices, driven by technological advancement and patient-centered care solutions.

Overall, the segmentation within the US Oxygen Therapy Device Market highlights the multifaceted applications and increasing significance of oxygen therapy across various health-related settings.

#### **Oxygen Therapy Device Market Technology Insights**

The US Oxygen Therapy Device Market, particularly the Technology segment, is evolving to meet the growing demand for effective respiratory support. Continuous Flow Technology has gained traction due to its reliability in delivering a consistent oxygen supply, making it a popular choice among patients with chronic respiratory conditions. Meanwhile, Pulse Dose Technology is noteworthy for its efficient oxygen delivery, providing doses based on the patient's breathing patterns, which enhances comfort and reduces wastage. Hybrid Oxygen Therapy represents an innovative blend of both methodologies, catering to diverse patient needs and ensuring optimal therapeutic effectiveness.

Key drivers of growth in the Technology segment include advancements in device portability, enhanced user-friendliness, and the increasing prevalence of respiratory diseases within the US population. As the understanding of chronic respiratory conditions improves, the demand for sophisticated oxygen therapy technologies continues to rise, pushing the boundaries of market capabilities. Challenges include regulatory hurdles and the need for ongoing Research and Development to enhance device efficacy and safety. However, opportunities for market expansion are substantial, particularly as home healthcare trends escalate, requiring advanced and adaptable oxygen delivery solutions.

### **US Oxygen Therapy Device Market Key Players and Competitive Insights**

The US Oxygen Therapy Device Market is characterized by a dynamic competitive landscape driven by growing awareness of respiratory disorders and the increasing prevalence of conditions such as chronic obstructive pulmonary disease (COPD). The market is marked by advancements in technology and innovative product offerings that enhance patient care and treatment outcomes. Companies in this sector are focusing on expanding their market presence through strategic partnerships, mergers, and acquisitions, enabling them to leverage resources, broaden their product lines, and enhance distribution channels.

As players strive to gain a competitive edge, differentiating their products while ensuring compliance with regulatory standards is crucial for achieving sustained growth in this evolving market.

O2 Concepts has established a notable presence in the US Oxygen Therapy Device Market through its commitment to innovation and quality. The company specializes in developing lightweight and portable oxygen concentrators that cater to the needs of patients requiring supplemental oxygen. Its emphasis on user-friendly designs and advanced technology positions O2 Concepts favorably amidst rising patient demands for mobility and convenience. The company's ability to provide reliable and effective oxygen delivery solutions has garnered positive recognition, contributing to its reputation as a trusted brand within the market.

By focusing on enhancing patient experience and comfort, O2 Concepts continues to strengthen its foothold in the highly competitive oxygen therapy landscape.

Linde Healthcare showcases a robust portfolio in the US Oxygen Therapy Device Market, offering a wide array of products that include oxygen concentrators, liquid oxygen systems, and portable cylinders. The company benefits from a strong distribution network and established relationships with healthcare professionals and institutions across the region. Linde Healthcare's strengths stem from its focus on research and development, leading to innovative therapeutic solutions that cater to numerous respiratory conditions. Additionally, the company has engaged in strategic mergers and acquisitions that bolster its market presence and expand its capabilities.

This strategic approach not only enhances Linde Healthcare’s product offerings but also enables it to deliver comprehensive services to patients, affirming its position as a leader in the oxygen therapy device sector within the US market.

### **Key Companies in the US Oxygen Therapy Device Market Include**

### **US Oxygen Therapy Device Market Industry Developments**

In recent developments within the US Oxygen Therapy Device Market, several key players have made notable advancements. O2 Concepts has been at the forefront of innovation with their portable oxygen concentrators that are increasingly favored by healthcare providers. Linde Healthcare has also expanded its product line to meet growing demand amid an aging population and rising prevalence of respiratory diseases. In September 2023, Medtronic launched a new line of oxygen delivery systems aimed at improving patient outcomes in critical care settings, reflecting an industry trend towards enhanced technology integration.

Drive DeVilbiss Healthcare and Philips have collaborated on research initiatives focusing on the effects of long-term oxygen therapy, emphasizing patient monitoring and care, while ResMed continues to enhance its digital health capabilities. Notably, in June 2022, Invacare announced its strategic decision to acquire a complementary company, which further strengthened its market position. The US Oxygen Therapy Device Market is currently witnessing a significant uptick in valuation due to increased healthcare spending and advancements in device technology, resulting in improved quality of life for patients while driving competition among manufacturers.

### **US Oxygen Therapy Device Market Segmentation Insights**

#### **Oxygen Therapy Device Market Type Outlook**

#### **Oxygen Therapy Device Market Application Outlook**

#### **Oxygen Therapy Device Market End Use Outlook**

#### **Oxygen Therapy Device Market Technology Outlook**

## Market Drivers

### Rising Prevalence of Respiratory Disorders

oxygen therapy market Conditions such as chronic obstructive pulmonary disease (COPD) and asthma are becoming more prevalent, affecting millions of individuals. According to the Centers for Disease Control and Prevention (CDC), approximately 16 million Americans are diagnosed with COPD, which necessitates the use of [oxygen therapy devices](https://www.marketresearchfuture.com/reports/oxygen-therapy-device-market-2923). This growing patient population is likely to boost demand for various oxygen delivery systems, including portable oxygen concentrators and stationary systems. As healthcare providers seek to improve patient outcomes, the oxygen therapy-device market is expected to expand significantly, with projections indicating a growth rate of around 8% annually over the next few years. This trend underscores the critical role that oxygen therapy plays in managing chronic respiratory conditions and enhancing the quality of life for affected individuals.

### Increased Focus on Home Healthcare Solutions

The shift towards home healthcare solutions is a pivotal driver for the oxygen therapy-device market. With a growing emphasis on patient-centered care, healthcare providers are increasingly recommending home-based oxygen therapy for patients with chronic respiratory conditions. This trend is supported by the rising costs of hospital stays and the desire for patients to receive care in the comfort of their homes. The oxygen therapy-device market is benefiting from this transition, as more patients opt for home oxygen therapy systems. According to industry reports, the home healthcare segment is projected to account for over 50% of the market share by 2026. This shift not only enhances patient satisfaction but also reduces the burden on healthcare facilities, indicating a promising future for the oxygen therapy-device market as home healthcare continues to expand.

### Regulatory Support and Reimbursement Policies

Regulatory support and favorable reimbursement policies are crucial drivers for the oxygen therapy-device market. The US government has implemented various policies to ensure that patients have access to necessary medical devices, including oxygen therapy systems. Medicare and Medicaid programs provide coverage for oxygen therapy, which encourages patients to seek treatment. This financial support is vital for individuals who may otherwise be unable to afford such devices. Additionally, the Food and Drug Administration (FDA) continues to streamline the approval process for new oxygen therapy devices, fostering innovation within the market. As reimbursement policies evolve to include more comprehensive coverage for home healthcare solutions, the oxygen therapy-device market is likely to experience sustained growth. Projections indicate that the market could reach a valuation of $4 billion by 2028, driven by these supportive regulatory frameworks.

### Aging Population and Increased Healthcare Needs

oxygen therapy market As individuals age, they often experience a decline in lung function and an increased risk of respiratory diseases. The US Census Bureau projects that by 2030, all baby boomers will be over 65 years old, leading to a surge in healthcare needs, including oxygen therapy. This demographic shift is likely to drive demand for oxygen therapy devices, as older adults are more susceptible to conditions requiring supplemental oxygen. Furthermore, the healthcare system is adapting to cater to this demographic, with a focus on home healthcare solutions. The oxygen therapy-device market is poised for growth, with estimates suggesting a market value exceeding $3 billion by 2027, reflecting the increasing reliance on oxygen therapy for the elderly population.

### Technological Innovations in Oxygen Delivery Systems

Technological advancements in oxygen delivery systems are reshaping the oxygen therapy-device market. Innovations such as portable oxygen concentrators, which are lightweight and user-friendly, are gaining traction among patients who require mobility. These devices offer a more convenient alternative to traditional oxygen tanks, allowing users to maintain an active lifestyle. Additionally, advancements in smart technology, including mobile applications that monitor oxygen levels, are enhancing patient engagement and adherence to therapy. The integration of telehealth services with oxygen therapy is also emerging, enabling healthcare providers to remotely monitor patients' conditions. This trend is likely to drive market growth, as patients increasingly seek devices that offer both functionality and ease of use. The oxygen therapy-device market is expected to witness a compound annual growth rate (CAGR) of approximately 7% over the next five years, driven by these technological innovations.

## Future Outlook

The oxygen therapy market is projected to grow at a 6.82% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence of respiratory diseases, and rising healthcare expenditure.

**New opportunities:**

- Development of [portable oxygen concentrators](https://www.marketresearchfuture.com/reports/portable-oxygen-concentrator-market-43273) for home use
- Integration of telehealth solutions for remote monitoring
- Expansion of oxygen therapy services in outpatient settings

By 2035, the market is expected to achieve substantial growth, driven by innovation and increased demand.

## Segment Insights

### By Type: Oxygen Concentrators (Largest) vs. Portable Oxygen Devices (Fastest-Growing)

In the US oxygen therapy-device market, Oxygen Concentrators hold the largest market share, significantly due to their efficiency and convenience. Following them are Portable Oxygen Devices, which are rapidly gaining traction among users seeking mobility and independence in their oxygen therapy. Other segment values, such as Liquid Oxygen Systems and Oxygen Cylinders, present smaller shares but are valued for specific applications and patient needs. Oxygen Accessories complete the category, providing essential support in the therapy process.

Growth trends show a marked increase in demand for Portable Oxygen Devices, attributed to an aging population and rising awareness of chronic respiratory conditions. Technological advancements are also driving innovation, particularly in making devices more user-friendly and portable. As healthcare continues to evolve, the emphasis on home care solutions positively impacts the market dynamics, with Oxygen Concentrators remaining integral due to their established efficacy and reliability.

Oxygen Concentrators (Dominant) vs. Portable Oxygen Devices (Emerging)

Oxygen Concentrators are considered the dominant segment within the US oxygen therapy-device market, well-regarded for their ability to provide a continuous flow of oxygen with minimal maintenance. They cater primarily to patients who require long-term therapy and are often preferred in home care settings. In contrast, Portable Oxygen Devices represent an emerging sector, appealing to patients needing mobility without compromising their oxygen therapy needs. These devices offer flexibility and convenience, enhancing the quality of life for users. Both segment values highlight the market's adaptability to consumer preferences, where traditional devices meet the rising demand for on-the-go solutions.

### By Application: Chronic Obstructive Pulmonary Disease (Largest) vs. Asthma (Fastest-Growing)

In the US oxygen therapy-device market, Chronic Obstructive Pulmonary Disease (COPD) constitutes the largest application segment, covering a significant portion of market share. This condition affects millions and requires ongoing oxygen therapy for management, resulting in a substantial demand for related devices. Meanwhile, asthma emerges as a rapidly expanding segment, reflecting a growing awareness and diagnosis of the condition, leading to increased demand for oxygen therapy solutions.

The growth trends in this segment are driven by an aging population, rising pollution levels, and greater awareness about respiratory health. The increasing prevalence of chronic conditions like COPD and asthma is expected to fuel the market further. Innovations in oxygen delivery technologies and an emphasis on home care therapies are also contributing to the expansion of these application segments, particularly for asthma, indicating a shift towards more personalized treatment options.

Chronic Obstructive Pulmonary Disease (Dominant) vs. Asthma (Emerging)

Chronic Obstructive Pulmonary Disease (COPD) remains the dominant force within the US oxygen therapy-device market, characterized by a large patient base reliant on continuous oxygen support. This segment's stability stems from its chronic nature, demanding long-term treatment solutions that include portable and home-based oxygen devices. Conversely, asthma represents an emerging segment where innovative therapies and personalized medicine are gaining traction. Patients are increasingly opting for advanced technologies that provide more effective management of asthma attacks and overall respiratory health. The shift towards smart devices and wearables for real-time monitoring further positions asthma as a significant potential growth area in the market.

### By End Use: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

In the US oxygen therapy-device market, hospitals dominate the end-use segment, holding a substantial market share due to the high demand for oxygen therapy in acute medical settings. Home care settings follow closely, experiencing growth as patients increasingly prefer receiving care in their own environments. Emergency medical services and long-term care facilities represent smaller shares, though they play critical roles in delivering oxygen therapy to broader populations.

Growth trends indicate that home care settings are emerging as the fastest-growing segment, driven by an aging population and the rising prevalence of chronic respiratory diseases. Technological advancements and the increasing adoption of portable oxygen devices further fuel this growth. Hospitals remain essential, but the shift towards home care reflects broader healthcare trends favoring patient-centered approaches and cost-effective solutions.

Hospitals (Dominant) vs. Home Care Settings (Emerging)

Hospitals play a dominant role in the oxygen therapy-device market as they cater to a critical need for oxygen support in critical care units and emergency departments. These settings capitalize on robust infrastructure, trained professionals, and a high volume of patients requiring immediate respiratory assistance. Meanwhile, home care settings are establishing themselves as an emerging force, driven by innovations in portable oxygen technologies and a shift in patient preferences towards at-home care. This segment is characterized by personalized care solutions, leveraging telehealth and remote monitoring, thus catering to chronic illness management. Both segments reflect the ongoing evolution of healthcare, balancing the need for immediate access in hospitals with the convenience and comfort of care at home.

### By Technology: Continuous Flow Technology (Largest) vs. Pulse Dose Technology (Fastest-Growing)

In the US oxygen therapy-device market, Continuous Flow Technology holds the largest market share, largely due to its reliability and effectiveness in providing a consistent oxygen flow for patients requiring long-term therapy. This segment appeals significantly to older adults and chronic respiratory illness patients, who often prioritize continuous oxygen supply over novelty or ease of use. On the other hand, Pulse Dose Technology is gaining traction and is seen as the fastest-growing segment, primarily driven by advancements in technology that enhance portability and usability, making it ideal for active patients.

Growth trends in these segments are influenced by an increasing aging population and rising prevalence of chronic respiratory diseases. Continuous Flow Technology's dominance is bolstered by healthcare providers' preference for established devices in clinical settings, whilst the rapid adoption of Pulse Dose Technology is propelled by demand for more mobile and discreet options among users. Furthermore, advancements in hybrid solutions that combine both technologies are fostering innovation in the market, offering patients tailored therapeutic options.

Technology: Continuous Flow Technology (Dominant) vs. Pulse Dose Technology (Emerging)

Continuous Flow Technology remains the dominant force in the US oxygen therapy-device market, celebrated for its proven reliability and effectiveness in delivering a continuous supply of oxygen. This technology appeals to patients who require consistent therapy, particularly the elderly and those with severe respiratory conditions. Its established presence in hospitals makes it a trusted choice among healthcare professionals. In contrast, Pulse Dose Technology is emerging rapidly, captivating users with its portable design and on-demand delivery capability. Designed for patients who enjoy mobility, this technology allows for discreet usage, making it popular among younger, active patients. The surge in interest for hybrid oxygen therapy solutions further highlights the flexibility and evolving landscape of oxygen delivery methods.

## Competitive Benchmarking

The oxygen therapy-device market is characterized by a dynamic competitive landscape, driven by increasing demand for respiratory care solutions and advancements in technology. Key players such as Philips (NL), ResMed (AU), and Invacare (US) are strategically positioned to leverage innovation and expand their market presence. Philips (NL) focuses on enhancing patient outcomes through digital health solutions, while ResMed (AU) emphasizes cloud-connected devices that facilitate remote monitoring. Invacare (US) is concentrating on product diversification and improving accessibility to its devices, which collectively shapes a competitive environment that prioritizes technological advancement and patient-centric solutions.The market structure appears moderately fragmented, with several players vying for market share. Companies are adopting various business tactics, such as localizing manufacturing to reduce costs and optimize supply chains. This approach not only enhances operational efficiency but also allows for quicker response times to market demands. The collective influence of these key players fosters a competitive atmosphere where innovation and customer service are paramount, driving the overall growth of the market.

In October  ResMed (AU) announced a partnership with a leading telehealth provider to integrate its devices with remote patient monitoring systems. This strategic move is likely to enhance patient engagement and adherence to therapy, positioning ResMed as a leader in the digital health space. The integration of telehealth capabilities with oxygen therapy devices may significantly improve patient outcomes and streamline healthcare delivery.

In September  Philips (NL) launched a new portable oxygen concentrator designed for active lifestyles, which is equipped with advanced battery technology. This product launch reflects Philips' commitment to innovation and meeting the needs of a growing demographic of mobile patients. The introduction of such devices may not only capture market share but also reinforce Philips' reputation as a pioneer in respiratory care technology.

In August  Invacare (US) expanded its product line by introducing a new range of lightweight oxygen therapy devices aimed at enhancing mobility for users. This expansion is indicative of Invacare's strategy to diversify its offerings and cater to the evolving needs of patients. By focusing on lightweight and user-friendly designs, Invacare may strengthen its competitive position in the market.

As of November  current trends in the oxygen therapy-device market include a pronounced shift towards digitalization, sustainability, and the integration of artificial intelligence (AI) in product development. Strategic alliances are increasingly shaping the landscape, enabling companies to pool resources and expertise. The competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, technology, and supply chain reliability, as companies strive to meet the growing expectations of healthcare providers and patients alike.

## Recent News & Developments

In recent developments within the US Oxygen Therapy Device Market, several key players have made notable advancements. O2 Concepts has been at the forefront of innovation with their portable oxygen concentrators that are increasingly favored by healthcare providers. Linde Healthcare has also expanded its product line to meet growing demand amid an aging population and rising prevalence of respiratory diseases. In September 2023, Medtronic launched a new line of oxygen delivery systems aimed at improving patient outcomes in critical care settings, reflecting an industry trend towards enhanced technology integration.

Drive DeVilbiss Healthcare and Philips have collaborated on research initiatives focusing on the effects of long-term oxygen therapy, emphasizing patient monitoring and care, while ResMed continues to enhance its digital health capabilities. Notably, in June 2022, Invacare announced its strategic decision to acquire a complementary company, which further strengthened its market position. The US Oxygen Therapy Device Market is currently witnessing a significant uptick in valuation due to increased healthcare spending and advancements in device technology, resulting in improved quality of life for patients while driving competition among manufacturers.

## Report Scope

| MARKET SIZE 2024 | 594.08(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 634.6(USD Million) |
| MARKET SIZE 2035 | 1227.54(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.82% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Philips (NL), ResMed (AU), Breas Medical (SE), Invacare (US), AirSep Corporation (US), OxyGo (US), DeVilbiss Healthcare (US), Nidek Medical (JP), Caire Inc. (US) |
| Segments Covered | Type, Application, End Use, Technology |
| Key Market Opportunities | Integration of advanced telehealth solutions enhances accessibility in the oxygen therapy-device market. |
| Key Market Dynamics | Technological advancements drive innovation in oxygen therapy devices, enhancing patient outcomes and market competitiveness. |
| Countries Covered | US |

## Frequently Asked Questions

**Q: What is the current valuation of the US oxygen therapy-device market?**
A: The market valuation was $594.08 Million in 2024.

**Q: What is the projected market valuation for the US oxygen therapy-device market by 2035?**
A: The projected valuation for 2035 is $1227.54 Million.

**Q: What is the expected CAGR for the US oxygen therapy-device market during the forecast period 2025 - 2035?**
A: The expected CAGR is 6.82% during the forecast period.

**Q: Which segment had the highest valuation in the US oxygen therapy-device market in 2024?**
A: The Home Care Settings segment had a valuation of $250.0 - $500.0 Million.

**Q: What are the key applications driving the US oxygen therapy-device market?**
A: Key applications include Chronic Obstructive Pulmonary Disease and Sleep Apnea, with valuations of $200.0 - $400.0 Million and $120.0 - $240.0 Million, respectively.

**Q: Which technology segment is expected to grow significantly in the US oxygen therapy-device market?**
A: The Pulse Dose Technology segment is projected to grow, with a valuation range of $250.0 - $500.0 Million.

**Q: Who are the leading players in the US oxygen therapy-device market?**
A: Key players include Philips, ResMed, and Invacare, among others.

**Q: What is the valuation range for Oxygen Concentrators in the US oxygen therapy-device market?**
A: The valuation range for Oxygen Concentrators is $200.0 - $400.0 Million.

**Q: How does the valuation of Liquid Oxygen Systems compare to Oxygen Cylinders?**
A: Liquid Oxygen Systems had a valuation of $100.0 - $200.0 Million, whereas Oxygen Cylinders ranged from $150.0 - $300.0 Million.

**Q: What is the expected growth trend for the US oxygen therapy-device market in the coming years?**
A: The market is likely to experience steady growth, driven by an expected CAGR of 6.82% from 2025 - 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/us-oxygen-therapy-device-market-17985*